XML 26 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 5 - Fair Value Measurements
12 Months Ended
Sep. 30, 2018
Notes to Financial Statements  
Fair Value Disclosures [Text Block]
5.
FAIR VALUE MEASUREMENTS
 
The Company’s financial instruments consist principally of cash equivalents, short and long-term marketable securities, accounts receivable and accounts payable. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or
not
the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into
three
levels (with Level
3
being the lowest) defined as follows:
 
 
Level
1:
Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.
 
 
Level
2:
Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are
not
active near the measurement date.
 
 
Level
3:
Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.
 
The fair value of the majority of the Company’s cash equivalents and marketable securities was determined based on “Level
1”
inputs. The fair value of certain marketable securities, long-term debt, hedge fund investments, and derivative contracts were determined based on “Level
2”
inputs. The valuation techniques used to measure the fair value of the “Level
2”
instruments were valued based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. The Company does
not
have any financial instruments measured at fair value on a recurring basis in the “Level
3”
category.
 
There have been
no
changes in Level
1,
Level
2,
and Level
3
and
no
changes in valuation techniques for financial instruments measured at fair value on a recurring basis for the years ended
September 30, 2018
and
2017.
 
Instruments Measured at Fair Value
on a Recurring Basis
 
The following tables present the Company’s cash equivalents and marketable securities’ costs, gross unrealized gains and losses, and fair value by major security type recorded as cash equivalents or short-term or long-term marketable securities as of
September 30, 2018
and
2017.
 
   
September 30, 2018
 
   
 
 
 
 
Unrealized
   
Fair
   
Cash
   
Short-term
   
Long-term
 
   
Cost Basis
   
Losses
   
Value
   
Equivalents
   
Securities
   
Securities
 
Level 1:
                                               
Money Market Funds
  $
410,393
    $
-
    $
410,393
    $
410,393
    $
-
    $
-
 
                                                 
Level 2:
                                               
Certificates of deposit
   
499,000
     
-
     
499,000
     
-
     
-
     
499,000
 
Municipal securities
   
-
     
-
     
-
     
-
     
-
     
-
 
Corporate bonds
   
4,302,661
     
(8,945
)    
4,293,716
     
-
     
3,592,175
     
701,541
 
Subtotal
   
4,801,661
     
(8,945
)    
4,792,716
     
-
     
3,592,175
     
1,200,541
 
                                                 
Total
  $
5,212,054
    $
(8,945
)   $
5,203,109
    $
410,393
    $
3,592,175
    $
1,200,541
 
 
 
   
September 30, 2017
 
   
 
 
 
 
 
   
Fair
   
Cash
   
Short-term
   
Long-term
 
   
Cost Basis
   
Losses
   
Value
   
Equivalents
   
Securities
   
Securities
 
                                                 
Level 1:
                                               
Money Market Funds
  $
55,257
    $
-
    $
55,257
    $
55,257
    $
-
    $
-
 
                                                 
Level 2:
                                               
Certificates of deposit
   
2,436,647
     
-
     
2,436,647
     
-
     
1,937,647
     
499,000
 
Municipal securities
   
25,315
     
(12
)    
25,303
     
-
     
25,303
     
-
 
Corporate bonds
   
2,609,973
     
(1,257
)    
2,608,716
     
-
     
2,396,592
     
212,124
 
Subtotal
   
5,071,935
     
(1,269
)    
5,070,666
     
-
     
4,359,542
     
711,124
 
                                                 
Total
  $
5,127,192
    $
(1,269
)   $
5,125,923
    $
55,257
    $
4,359,542
    $
711,124
 
 
 
Instruments Measured at Fair Value
on a Non-Recurring Basis
 
Assets and liabilities that are measured at fair value on a non-recurring basis include intangible assets and goodwill, which are recognized at fair value during the period in which an acquisition is completed, from updated estimates and assumptions during the measurement period, or when they are considered to be impaired. These non-recurring fair value measurements, primarily for intangible assets acquired, were based on Level
3
unobservable inputs. In the event of an impairment, the Company determines the fair value of the goodwill and intangible assets using a discounted cash flow approach, which contains significant unobservable inputs and therefore is considered a Level
3
fair value measurement. The unobservable inputs in the analysis generally include future cash flow projections and a discount rate.
 
The following table presents categories of long-lived assets that were subject to non-recurring fair value measurements during the year ended 
September 30, 2018:
 
   
 
 
 
 
Fair Value Measurements at September 30, 2018
   
 
 
 
   
Carrying Value
   
Active Markets for Identifiable Assets
(Level 1)
   
Observable Inputs
(Level 2)
   
Unobservable Inputs
(Level 3)
   
Non-Cash
Impairment
Loss
 
Intangible assets from Genasys acquisition
(a)
  $
1,520,006
    $
-
    $
-
    $
1,520,006
    $
-
 
Goodwill from Genasys acquisition
(b)
  $
2,445,990
    $
-
    $
-
    $
2,445,990
    $
-
 
Patents
(c)
  $
37,340
    $
-
    $
-
    $
37,340
    $
(11,133
)
 
 
(a)
Represents acquired intangible assets from the acquisition of Genasys. There was
no
impairment related to these assets. (See Note
4,
Acquisition and Note
8,
Goodwill and Intangible Assets, for more information)
 
 
(b)
Represents acquired goodwill from the acquisition of Genasys. There was
no
impairment related to these assets. (See Note
4,
Acquisition and Note
8,
Goodwill and Intangible Assets, for more information)
 
 
(c)
During the year ended
September 30, 2018,
the Company determined that certain patents were impaired. The impaired patents related to products
no
longer sold by the Company.
 
The following table presents categories of long-lived assets that were subject to non-recurring fair value measurements during the year ended 
September 30, 2017:
 
   
 
 
 
 
Fair Value Measurements at September 30, 2017
   
 
 
 
   
Carrying Value
   
Active Markets for Identifiable Assets
(Level 1)
   
Observable Inputs
(Level 2)
   
Unobservable Inputs
(Level 3)
   
Non-Cash
Impairment
Loss
 
Patents
  $
55,689
    $
-
    $
-
    $
55,689
    $
-
 
 
 
The Company did
not
recognize non-recurring fair value adjustments related to the impairment of intangible assets for the year ended
September 30, 2017.